Precedent Wealth Partners, LLC Abb Vie Inc. Transaction History
Precedent Wealth Partners, LLC
- $306 Billion
- Q4 2024
A detailed history of Precedent Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Precedent Wealth Partners, LLC holds 9,222 shares of ABBV stock, worth $1.89 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
9,222
Previous 8,839
4.33%
Holding current value
$1.89 Million
Previous $1.75 Billion
6.11%
% of portfolio
0.53%
Previous 0.58%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
4,111Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$35.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$28 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.3 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.6 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.15 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $363B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...